Jeryl L. Hilleman, Chief Financial Officer at Intersect ENT, Inc. (XENT), sold 21,200 shares at $32.34 ($686K) on 2019-04-02, disclosed to the SEC on 2019-04-03.
Open-market sale of $686k XENT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.34 | 4,709 | $152K | 22.2% |
| 2 | $32.34 | 16,491 | $533K | 77.8% |
| Total | $32.34 avg | 21,200 | $686K | 100% |
| Filing → |
| SIBN | SELL | 2023-06-20 | $178K | — | Filing → |
| NVCR | SELL | 2022-06-16 | $28K | — | Filing → |
| SIBN | SELL | 2022-06-14 | $27K | — | Filing → |